閻 雲

研究成果

每年研究成果 1994 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2018 2019 2021 2023

• 303 文章
• 22 回顧型文獻
• 5 評論/辯論
• 4 章節
• 7 更多
  • 4 快報
  • 2 簡短的問卷調查
  • 1 會議貢獻

每年研究成果

每年研究成果

搜尋結果

• 2016

  Polymeric nanoparticles and cancer: Lessons learnt from CRLX101

  Gritli, I., Garmey, E., Eliasof, S., Tellez, A., Davis, M. E. & Yun, Y., 2016, Privileged Scaffolds in Medicinal Chemistry: Design, Synthesis, Evaluation. 51 編輯 Royal Society of Chemistry, 卷 2016-January. p. 199-232 34 p. (RSC Drug Discovery Series; 卷 2016-January, 編號 51).

  研究成果: 書貢獻/報告類型 › 章節

  • IT-101 100%
  • Camptothecin 60%
  • Nanoparticles 42%
  • Antiangiogenic 32%
  • Clearance 25%
  5 引文 斯高帕斯（Scopus）
• 2009

  Alternative splicing as a therapeutic target for human diseases

  Dery, K. J., Gusti, V., Gaur, S., Shively, J. E., Yen, Y. & Gaur, R. K., 12月 1 2009, Therapeutic Applications of RNAi: Methods and Protocols. Reidhaar-Olson, J. & Rondinone, C. (編輯). p. 127-144 18 p. (Methods in Molecular Biology; 卷 555).

  研究成果: 書貢獻/報告類型 › 章節

  • Alternative Splicing 100%
  • Riboswitch 70%
  • RNA Precursors 52%
  • Theophylline 51%
  • Genetic Association Studies 48%
  11 引文 斯高帕斯（Scopus）
• 2008

  Redox property of ribonucleotide reductase small subunit M2 and p53R2

  Liu, X., Xue, L. & Yen, Y., 2008, Advanced Protocols in Oxidative Stress I. Armstrong, D., Armstrong, D. & Armstrong, D. (編輯). p. 195-206 12 p. (Methods in Molecular Biology; 卷 477).

  研究成果: 書貢獻/報告類型 › 章節

  • ribonucleotide reductase M2 100%
  • Oxidation-Reduction 53%
  • Reactive Oxygen Species 44%
  • Mitochondrial Membrane Potential 39%
  • Oxidative Stress 27%
  18 引文 斯高帕斯（Scopus）
• 2005

  8 Growth arrest DMA damage-inducible gene 45 β in human hepatocellular carcinoma

  Yen, Y., 12月 1 2005, Molecular Genetics, Liver Carcinoma, and Pancreatic Carcinoma. Hayat, M. A. (編輯). p. 207-215 9 p. (Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas; 卷 3).

  研究成果: 書貢獻/報告類型 › 章節